Samer El-Dika
Research Subjects
Research Interests
Samer El-Dika has a total of 17 co-authors. Here are the top co-authors by number of shared publications:
- Alan N. Barkun
Division of Gastroenterology, McGill University Health Center, McGill University, Montreal, Quebec, Canada
2 shared publications - Alessio Degl' Innocenti
AstraZeneca R&D, Clinical Science, Mölndal, Sweden
2 shared publications - Carlo A. Fallone
Division of Gastroenterology, McGill University Health Center, Montreal, Quebec, Canada
2 shared publications - David Armstrong
McMaster University
2 shared publications - Diane Heels-Ansdell
Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, Canada
2 shared publications - Gordon Henry Guyatt
Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, Canada
2 shared publications
Latest Publications
- Open Access
- 3 June 2008
- Published by Springer Nature in Journal of General Internal Medicine
- Vol. 23 (9) , 1525-1527
An Unusual Case of Hematochezia: Acute Ischemic Proctosigmoiditis
- 3 June 2008
- Published by Springer Nature in Journal of General Internal Medicine
- Vol. 23 (9) , 1525-1527
Open AccessAn Unusual Case of Hematochezia: Acute Ischemic Proctosigmoiditis
- Open Access
- 10 July 2005
- Published by Springer Nature in BMC Gastroenterology
- Vol. 5 (1) , 23
The impact of illness in patients with moderate to severe gastro-esophageal reflux disease
Background Gastro-esophageal reflux disease (GERD) is a common disease. It impairs health related quality of life (HRQL). However, the impact on utility scores and work productivity in patients with moderate to severe GERD is not well known. Methods We analyzed data from 217 patients with moderate to severe GERD (mean age 50, SD 13.7) across 17 Canadian centers. Patients completed three utility instruments – the standard gamble (SG), the feeling thermometer (FT), and the Health Utilities Index 3 (HUI 3) – and several HRQL instruments, including Quality of Life in Reflux and Dyspepsia (QOLRAD) and the Medical Outcomes Short Form-36 (SF-36). All patients received a proton pump inhibitor, esomeprazole 40 mg daily, for four to six weeks. Results The mean scores on a scale from 0 (dead) to 1 (full health) obtained for the FT, SG, and HUI 3 were 0.67 (95% CI, 0.64 to 0.70), 0.76 (95% CI, 0.75 to 0.80), and 0.80 (95% CI, 0.77 to 0.82) respectively. The mean scores on the SF-36 were lower than the previously reported Canadian and US general population mean scores and work productivity was impaired. Conclusion GERD has significant impact on utility scores, HRQL, and work productivity in patients with moderate to severe disease. Furthermore, the FT and HUI 3 provide more valid measurements of HRQL in GERD than the SG. After treatment with esomeprazole, patients showed improved HRQL.
- 10 July 2005
- Published by Springer Nature in BMC Gastroenterology
- Vol. 5 (1) , 23
Open AccessThe impact of illness in patients with moderate to severe gastro-esophageal reflux disease
Background Gastro-esophageal reflux disease (GERD) is a common disease. It impairs health related quality of life (HRQL). However, the impact on utility scores and work productivity in patients with moderate to severe GERD is not well known. Methods We analyzed data from 217 patients with moderate to severe GERD (mean age 50, SD 13.7) across 17 Canadian centers. Patients completed three utility instruments – the standard gamble (SG), the feeling thermometer (FT), and the Health Utilities Index 3 (HUI 3) – and several HRQL instruments, including Quality of Life in Reflux and Dyspepsia (QOLRAD) and the Medical Outcomes Short Form-36 (SF-36). All patients received a proton pump inhibitor, esomeprazole 40 mg daily, for four to six weeks. Results The mean scores on a scale from 0 (dead) to 1 (full health) obtained for the FT, SG, and HUI 3 were 0.67 (95% CI, 0.64 to 0.70), 0.76 (95% CI, 0.75 to 0.80), and 0.80 (95% CI, 0.77 to 0.82) respectively. The mean scores on the SF-36 were lower than the previously reported Canadian and US general population mean scores and work productivity was impaired. Conclusion GERD has significant impact on utility scores, HRQL, and work productivity in patients with moderate to severe disease. Furthermore, the FT and HUI 3 provide more valid measurements of HRQL in GERD than the SG. After treatment with esomeprazole, patients showed improved HRQL.
- Open Access
- 1 January 2005
- Published by Springer Nature in Health and Quality of Life Outcomes
- Vol. 3 (1) , 1-4
The influence of demographic factors and health-related quality of life on treatment satisfaction in patients with gastroesophageal reflux disease treated with esomeprazole
The correlation between treatment satisfaction and demographic characteristics, symptoms, or health-related quality of life (HRQL) in patients with gastroesophageal reflux disease (GERD) is unknown. The objective of this study was to assess correlates of treatment satisfaction in patients with GERD receiving a proton pump inhibitor, esomeprazole.
- 1 January 2005
- Published by Springer Nature in Health and Quality of Life Outcomes
- Vol. 3 (1) , 1-4
Open AccessThe influence of demographic factors and health-related quality of life on treatment satisfaction in patients with gastroesophageal reflux disease treated with esomeprazole
The correlation between treatment satisfaction and demographic characteristics, symptoms, or health-related quality of life (HRQL) in patients with gastroesophageal reflux disease (GERD) is unknown. The objective of this study was to assess correlates of treatment satisfaction in patients with GERD receiving a proton pump inhibitor, esomeprazole.